Home

Sjældent komponent Tilsvarende teva pharmaceuticals generic products Sælger Normalisering Rundt og rundt

Israel's Teva on FDA blacklist of drugmakers creating barriers to  competition | The Times of Israel
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel

Generic medicines
Generic medicines

Teva sells its only manufacturing plant in Russia
Teva sells its only manufacturing plant in Russia

The Teva-Allergan deal shows why pharma mergers are booming | Fortune
The Teva-Allergan deal shows why pharma mergers are booming | Fortune

Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State  Prosecutors Say - The New York Times
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times

Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum |  AlphaStreet
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet

Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries

Teva's recall of U.S.-made drugs latest example of contamination fears in  generic marketplace; report says Lilly, Pfizer and former Mylan plant in  Morgantown have been cited in the past | WV News
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News

Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) |  Seeking Alpha
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha

Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva Pharmaceuticals: Making Quality Health Care Accessible

Mayne Pharma to buy a portfolio of Teva's generic drugs for $652 million |  Pharmafile
Mayne Pharma to buy a portfolio of Teva's generic drugs for $652 million | Pharmafile

FDA approves a generic version of Teva Pharmaceutical's best-selling drug;  company shares tumble
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble

Teva Pharmaceuticals
Teva Pharmaceuticals

A Look at Teva's Generic Drugs Research Pipeline
A Look at Teva's Generic Drugs Research Pipeline

Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters

Teva Pharmaceuticals - Wikiwand
Teva Pharmaceuticals - Wikiwand

Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the  First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing  for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA |  BioSpace
Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA | BioSpace

Teva secures US regulatory approval for generic version of Sabril
Teva secures US regulatory approval for generic version of Sabril

Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)

Teva pharmaceuticals hi-res stock photography and images - Alamy
Teva pharmaceuticals hi-res stock photography and images - Alamy

Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma

Teva Pharmaceuticals Industries Ltd. | BioWorld
Teva Pharmaceuticals Industries Ltd. | BioWorld

Teva Announces New Brand Positioning and Visual Identity in North America
Teva Announces New Brand Positioning and Visual Identity in North America

Teva unifies pharmaceutical packaging worldwide | packagingdigest.com
Teva unifies pharmaceutical packaging worldwide | packagingdigest.com

Look out, Teva: Mylan's Copaxone copy has already captured serious share |  Fierce Pharma
Look out, Teva: Mylan's Copaxone copy has already captured serious share | Fierce Pharma

Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches ::  Scrip
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip

Teva, one of the biggest generic makers, joins the the brand-name club
Teva, one of the biggest generic makers, joins the the brand-name club